TMAO has been shown to enhance antitumor immunity in TNBC by activating the endoplasmic reticulum stress kinase PERK pathway, thus promoting CD8+ T cell-mediated immunity and ultimately leading to tumor cell pyroptosis. Here, EIF2AK3 is linked to neoplasm.